Cough/Cold Combination Final Monograph Includes Four-Ingredient Combos
This article was originally published in The Tan Sheet
Executive Summary
FDA has designated combinations of analgesic-antipyretic, expectorant and nasal decongestant ingredients, as well as analgesic-antipyretic, antitussive, expectorant and nasal decongestant combinations, as Category I in the final monograph on cough/cold combinations